Cyclooxygenase-2 expression in human soft-tissue sarcomas is related to epithelial differentation

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 2669-2674

  Lassus, Patrik ^a,c   Ristimäki, Ari ^a   Huuhtanen, Riikka ^a   Tukiainen, Erkki ^a   Asko Seljavaara, Sirpa ^a   Andersson, Leif C ^a   Miettinen, Markku ^b   Blomqvist, Carl ^a   Haglund, Caj ^a   Böhling, Tom ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c Toolo Hospital   (Finland)

Author keywords

Cox 2; Epithelial differentiation; Immunohistochemistry; Soft tissue sarcomas; STS

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LOCALIZATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA;

ADULT; AGED; CELL DIFFERENTIATION; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SARCOMA;

EID: 22944446796     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Vane JR, Bakhle YS and Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
2. Xie WL, Chipman JG, Robertson DL, Erikson RL and Simmons DL: Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692-2696, 1991.
3. Dubois RN, Abramso SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB and Lipsky PE: Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073, 1998.
4. Taketo MM: Cyclooxygenase-2 inhibitors in tumourigenesis (Part I). J Natl Cancer Inst 90: 1529-1536, 1998.
5. Taketo MM: Cyclooxygenase-2 inhibitors in tumourigenesis (Part II). J Natl Cancer Inst 90: 1609-1620, 1998.
6. Thun MJ: Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev 13: 269-277, 1994.
7. Koki AT, Leahy KM and Masferrer JL: Potential utility of Cox-2 inhibitors in chemoprevention and chemotherapy. Exp Opin Invest Drugs 8: 1623-1638, 1999.
8. van Rees B and Ristimäki A: Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol 36: 897-903, 2001.
9. Narko K, Ristimäki A, MacPhee M, Smith E, Haudenschild CC and Hla T: tumourigenic transformation of immortalized ECV endothelial cells by cyclooxygenase-1 overexpression. J Biol Chem 272: 21455-21460, 1997.
10. Tsujii M, Kawano S and DuBois RN: Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94: 3336-3340, 1997.
11. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93: 705-716, 1998.
12. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K: Antiangiogenic and antitumour activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000.
13. Enzinger J and Weiss S: In: Soft Tissue Tumours. St Louis: Mosby Yearbook Inc, pp. 4-9, 1995.
14. Ristimäki A, Nieminen O, Saukkonen K, Hotakainen K, Nordling S and Haglund C: Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol 155: 849-853, 2001.
15. Miettinen M, Limon J, Niezabitowski A and Lasota J: Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch 437: 275-283, 2000.
16. Kämäräinen M, Miettinen M, Seppälä M, von Boguslawsky K, Benassi MS, Bohling T and Andersson LC: Epithelial expression of glycodelin in biphasic synovial sarcomas. Int J Cancer 76: 487-490, 1998.
17. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE and Schror K: Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59: 198-204, 1999.
18. Murata H, Kawano S, Tsuji S, Sawaoka H, Kimura Y, Shiozaki H and Hori M: Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am J Gastroenterol 94: 451-455, 1999.
19. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H and Ristimaki A: Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 58: 4997-5001, 1998.
20. Deininger MH, Weller M, Streffer J, Mittelbronn M and Meyermann R: Patterns of cyclooxygenase-1 and -2 expression in human gliomas in vivo. Acta Neuropathol 98: 240-244, 1999.
21. Chida M and Voelkel NF: Effects of acute and chronic hypoxia on rat lung Cyclooxygenase. Am J Physiol 270: L872-878, 1996.
22. Schmedtje JF Jr, Ji YS, Liu WL, DuBois RN and Runge MS: Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 272: 601-608, 1997.
23. Bizik J, Kankuri E, Ristimaki A, Taieb A, Vapaatalo H, Lubitz W and Vaheri A: Cell-cell contacts trigger programmed necrosis and induce cyclooxygenase-2 expression. Cell Death Differ 11: 183-195, 2004.
24. Matsumoto Y, Ishiko O, Sumi T, Yoshida H, Deguchi M, Nakagawa E, Haba T, Wakasa K, Ogita S and Ando Y: Cyclo-oxygenase-2 expression in malignant mesenchymal tumours and related uterine lesions. Oncol Rep 8: 1225-1227, 2001.
25. Dickens DS, Kozielski R, Khan J, Forus A and Cripe TP: Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 5: 356-364, 2002.
26. Dickens DS, Kozielski R, Leavey PJ, Timmons C and Cripe TP: Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 25: 282-285, 2003.
27. Sutton KM, Wright M, Fondren G, Towle CA and Mankin HJ: Cyclooxygenase-2 expression in chondrosarcoma. Oncology 66: 275-280, 2004.
28. Wong E, DeLuca C, Boily C, Charleson S, Cromlish W, Denis D, Kargman S, Kennedy BP, Quellet M, Skorey K, O'Neill GP, Vickers PJ and Riendeau D: Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells. Inflammation Res 46: 51-59, 1997.
29. Kishi K, Petersen S, Petersen C, Hunter N, Mason K, Masferrer JL, Tofilon PJ and Milas L: Preferential enhancement of tumour radioresponse by a cyclooxygenase-2 inhibitor. Cancer Res 60: 1326-1331, 2000.
30. Moalic S, Liagre B, LeBail JC and Beneytout JL: Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygcnase-2 inhibitor. Int J Oncol 18: 533-540, 2001.
31. Dickens DS and Cripe TP: Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts. J Pediatr Hematol Oncol 25: 709-714, 2003.
32. Yamashita H, Osaki M, Honjo S, Yoshida H, Teshima R and Ito H: A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. Anticancer Res 23: 4671-4676, 2003.
33. Ito H, Duxbury M, Benoit E, Farivar RS, Gardner-Thorpe J, Zinner MJ, Ashley SW and Whang EE: Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. Biochem Biophys Res Commun 318: 594-600, 2004.